Clinical trial
A Phase IIa Study to Investigate the Efficacy and Safety Profile of GM-XANTHO in Pressure Ulcer Patients
NCT05199077 is registered in ClinicalTrials.gov with Xantho Biotechnology Co., LTD as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase IIa Study to Investigate the Efficacy and Safety Profile of GM-XANTHO in Pressure Ulcer Patients
- Lead sponsor
- Xantho Biotechnology Co., LTD
- Phase
- Phase 2
- Overall status
- Not yet recruiting
- Start date
- September 1, 2026
- Completion date
- April 30, 2029
- Enrollment
- 58 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.